Abstract
Ocular involvement is present in 50–60% of granulomatosis with polyangiitis (GPA) patients and can affect any part of the ocular globe. The present study describes ophthalmologic manifestations, association with systemic symptoms, disease activity and damage in GPA. A cross-sectional study was conducted including patients with GPA who underwent rheumatologic and ophthalmologic evaluation. Demographics, comorbidities, ophthalmologic symptoms, serologic markers, radiographic studies, disease activity and damage were assessed. Descriptive statistics, correlation, univariable logistic regression analyses, Student’s t, Mann–Whitney U, Chi-square and Fisher’s exact tests were performed. Fifty patients were included, 60% female, the median age was 56 years, disease duration 72.5 months. Nineteen (38%) patients had ocular manifestations at GPA diagnosis, scleritis being the most frequent; 27 (54%) patients presented ocular involvement during follow-up, repeated scleritis and dacryocystitis being the most common manifestations. Concomitant ophthalmic and sinonasal involvement was present in 12 (24%). Ocular and ENT damage occurred in 58% and 70%, respectively. Epiphora and blurred vision were the most frequent symptoms; scleromalacia and conjunctival hyperemia (27%) the most frequent clinical abnormalities. Ocular involvement at diagnosis was associated with concomitant ocular and sinonasal involvement at follow-up (OR 4.72, 95% CI 1.17–19.01, p = 0.01). Ocular involvement at follow-up was associated with age at GPA diagnosis (OR 0.94, 95% CI 0.90–0.99, p = 0.03), VDI (OR 1.29, 95% CI 1.03–1.61, p = 0.02), and ENT damage (OR 5.27, 95% CI 1.37–20.13, p = 0.01). In GPA, ocular involvement is frequent, therefore, non-ophthalmologist clinicians should be aware of this manifestation to reduce the risk of visual morbidity and organ damage.
Similar content being viewed by others
References
Solans-Laqué R, Fraile G, Rodriguez-Carballeira M et al (2017) Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity. Medicine (Baltimore) 96(8):e6083. https://doi.org/10.1097/MD.0000000000006083
Tan LT, Davagnanam I, Isa H et al (2014) Clinical and imaging features predictive of orbital granulomatosis with polyangiitis and the risk of systemic involvement. Ophthalmology 121:1304–1309
Schmidt J, Pulido JS, Matteson EL (2011) Ocular manifestations of systemic disease: antineutrophil cytoplasmic antibody-associated vasculitis. Curr Opin Ophthalmol 22:489–495
Gheita TA, Abd EI, Latif EM (2018) Relationship of ocular presentation in granulomatosis with polyangiitis to autoantibodies and disease activity. Z Rheumatol. https://doi.org/10.1007/s00393-018-0495-5
Papaliodis GN (2017) Ophthalmologic manifestations of systemic vasculitis. Curr Opin Ophthalmol 28:613–616
Ursea R, De Castro D, Bowen TJ et al (2015) The role of conjunctival biopsy in the diagnosis of granulomatosis with polyangiitis. J Ophthal Inflamm Infect 5:1
Rothschild PR, Pagnoux C, Seror R et al (2013) Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature. Semin Arthritis Rheum 42:507–514
Kubaisi B, Abu Samra K, Foster CS (2016) Granulomatosis with polyangiitis (Wegener’s disease): an updated review of ocular disease manifestations. Intractable Rare Dis Res 5:61–69
Biswas J, Babu K, Gopal L et al (2003) Ocular manifestations of Wegener’s granulomatosis. Analysis of nine cases. Indian J Ophthalmol 51:217–223
Generali E, Cantarini L, Selmi C (2015) Ocular involvement in systemic autoimmune diseases. Clin Rev Allerg Immunol 49:263–270
Vischio JA, McCrary CT (2008) Orbital Wegener’s granulomatosis: a case report and review of the literature. Clin Rheumatol 27:1333–1336
Tan LT, Davagnanam I, Isa H et al (2015) Clinical and imaging features of lacrimal gland involvement in granulomatosis with polyangiitis. Ophthalmology 122:2125–2129
Muller K, Lin JH (2014) Orbital granulomatosis with polyangiitis (Wegener granulomatosis): clinical and pathologic findings. Arch Pathol Lab Med 138:1110–1114
Kobayashi S, Fujimoto S (2013) Epidemiology of vasculitides: differences between Japan, Europe and North America. Clin Exp Nephrol 17:611–614
Katsuyama T, Sada KE, Makino H (2014) Current concept and epidemiology of systemic vasculitides. Allergol Int 63:505–513
Leavitt RY, Fauci AS, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1107
Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised International Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1–11
Annapureddy N, Elsallabi O, Baker J et al (2016) Patient-reported outcomes in ANCA-associated vasculitis. A comparison between Birmingham Vasculitis Activity Score and routine assessment of patient index data 3. Clin Rheumatol 35:395–400
Merkel PA, Aydin SZ, Boers M et al (2014) Current status of outcome measure development in vasculitis. J Rheumatol 41:593–598
Jiang B, Zhao YY, Wei SH (2013) Granulomatosis with polyangiitis: the relationship between ocular and nasal disease. Ocul Immunol Inflamm 21:115–118
Cai S, Papaliodis G, Lu L et al (2016) Ocular manifestations of ANCA-associated vasculitis. Arthritis Rheumatol 68(Suppl 10):573–586
Ungprasert P, Crowson CS, Cartin-Ceba R et al (2017) Clinical characteristics of inflammatory ocular disease in anti-neutrophil cytoplasmic antibody associated vasculitis: a retrospective cohort study. Rheumatology 56:1763–1770
Ahmed M, Niffenegger JH, Jakobiec FA et al (2008) Diagnosis of limited ophthalmic Wegener’s granulomatosis: distinctive pathologic features with ANCA test confirmation. Int Ophthalmol 28:35–46
Woo TL, Francis IC, Wilcsek GA et al (2001) Australasian orbital and adnexal Wegener’s granulomatosis. Ophthalmology 108:1535–1543
Pakalniskis MG, Berg AD, Policeni BA et al (2015) The many faces of granulomatosis with polyangiitis: a review of the head and neck imaging manifestations. AJR Am J Roentgenol 205:W619–W629
Pakrou N, Selva D, Leibovitch I (2006) Wegener’s granulomatosis: ophthalmic manifestations and management. Semin Arthritis Rheum 35:284–292
Acknowledgements
The authors thank Dr. Lauro Quintanilla-González for his assistance in the clinical evaluation of the patients, Dr. Luis Llorente and Professor Clifford E. Roberson for their valuable aid in revising and editing the manuscript.
Funding
The authors declare that this work was not supported by any grant or funding.
Author information
Authors and Affiliations
Contributions
AHA, AGC and AJF designed the study; AHA, AGC, AJF and CRG participated in acquisition of data; AHA and AGC analyzed and interpreted data; AHA, AGC, AJF and CRG drafted and revised the manuscript and agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Conflict of interest
AHA, AGC, AJF and CRG declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Hinojosa-Azaola, A., García-Castro, A., Juárez-Flores, A. et al. Clinical significance of ocular manifestations in granulomatosis with polyangiitis: association with sinonasal involvement and damage. Rheumatol Int 39, 489–495 (2019). https://doi.org/10.1007/s00296-019-04242-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-019-04242-7